Hannah McCormick
Payments from drug & device makers
Across 130 payments — averaging $30.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$847
- Regeneron Healthcare Solutions, Inc.$557
- AbbVie$459
- Sun Pharmaceutical Industries Inc.$324
- E.r. Squibb & Sons, L.L.C.$300
- Sanofi$284
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,81398%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 32 | $847 |
| Regeneron Healthcare Solutions, Inc. | 17 | $557 |
| AbbVie | 15 | $459 |
| Sun Pharmaceutical Industries Inc. | 9 | $324 |
| E.r. Squibb & Sons, L.L.C. | 10 | $300 |
| Sanofi | 14 | $284 |
| VYNE Pharmaceuticals Inc. | 4 | $194 |
| Novartis | 10 | $176 |
| Galderma Laboratories, L.p. | 4 | $159 |
| Stryker | 1 | $142 |
| KCI USA, Inc. | 1 | $116 |
| Pfizer | 2 | $109 |
| Johnson & Johnson | 2 | $42 |
| Fresenius Kabi USA, LLC | 1 | $32 |
| Lilly USA, LLC | 1 | $28 |
| LEO Pharma Inc. | 2 | $28 |
| UCB, Inc. | 1 | $26 |
| Dermavant Sciences, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Amgen | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPZELURA$453
- DUPIXENT$379
- DALL-MILES$142
- AMZEEQ$125
- Winlevi$125
- ACTIV.A.C.$116
- Humira$115
How this compares
$3,908 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 25 | $1,351 |
| Clobetasol Propionate | 13 | $392 |
| Ketoconazole | 14 | $247 |
Paid to pharmacies, not to this prescriber.
Other family in Tempe
- Taylor PiontekTempe$54K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Keith MorsePrescott$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.